Historical record - last NADAC effective date: 6/21/2023
Product Information
METFORMIN HCL ER 750 MG TABLET is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0626 per EA under NDC 70010049205. Its NADAC has been published 203 times since Aug 28, 2019.
FDA first approved this application on Mar 16, 2018. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010049205
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
6/21/2023
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209313FDA Approved
3/16/2018
TE Code
AB1
On Market Since
7/31/2018
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL ER 750 MG TABLET has been published 203 times since Aug 28, 2019, and over the history we have for it it has declined 8.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0626 per EA |
|---|---|
| All-time high | $0.0942 (Feb 10, 2021) |
| All-time low | $0.0553 (Jan 22, 2020) |
| Median price | $0.0691 |
| Average price | $0.0727 |
| Largest weekly change | +26.5% (Dec 23, 2020) |
| Weeks tracked | 203 |
| Tracking since | Aug 28, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-29.7%
All
-8.6%
Last surveyed Jul 12, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METFORMIN HCL ER 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL ER 750 MG TABLET, manufactured by Granules Pharmaceuticals Inc., is $0.0626 per EA (NDC 70010049205), effective Jul 12, 2023.
How has the price of METFORMIN HCL ER 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL ER 750 MG TABLET has declined 8.6%. It has been tracked across 203 weekly CMS publications since Aug 28, 2019.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL ER 750 MG TABLET?
Since Aug 28, 2019, the NADAC for METFORMIN HCL ER 750 MG TABLET has ranged from a low of $0.0553 (Jan 22, 2020) to a high of $0.0942 (Feb 10, 2021), with a median of $0.0691 per EA.
Are there cheaper alternatives to METFORMIN HCL ER 750 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METFORMIN HCL ER 750 MG TABLET, is $0.0542 per EA — about 13% below METFORMIN HCL ER 750 MG TABLET.
Who manufactures METFORMIN HCL ER 750 MG TABLET?
METFORMIN HCL ER 750 MG TABLET (NDC 70010049205) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.